-Bloomberg
Keybanc Maintains Overweight on Synopsys, Raises Price Target to $395
Keybanc analyst Jason Celino maintains Synopsys (NASDAQ:SNPS) with a Overweight and raises the price target from $347 to $395.
Related Posts
Abbott Labs Wins $2.1M Navy Contract For ‘Chemistry Analyzer-Bremerton’
https://sam.gov/opp/4fc7a3dc109e45ebb048a3dbf450b665/view
Arete Research Initiates Coverage On Confluent with Buy Rating, Announces Price Target of $115
Arete Research initiates coverage on Confluent (NASDAQ:CFLT) with a Buy rating and announces Price Target of $115.